Pharmaceutical imports are projected to reach nearly $4.3 billion in 2025.
Vietnam spent nearly $4.3 billion importing pharmaceuticals in 2015, a decrease of 2.4% compared to the previous year. The United States and the EU continued to be the leading supplier partners.
According to preliminary statistics from the Customs agency, Vietnam's pharmaceutical imports in 2025 will total nearly US$4.3 billion, a decrease of 2.4% compared to 2024. In December 2025 alone, the import value reached US$449.18 million, a sharp increase of 58.4% compared to November 2025, but still a decrease of 13.3% compared to the same period last year.
The United States leads the market in pharmaceutical supply.
In 2025, the United States surpassed other partners to become Vietnam's largest supplier of pharmaceuticals. Imports from the United States reached $514.88 million, a slight increase of 0.5% compared to 2024, and accounted for 12% of the country's total imports of this product group.
Second place goes to the French market with a value of $486.17 million. However, compared to 2024, imports from France have sharply decreased by 15.1%, accounting for 11.3% of the market share. Other major markets include Germany with over $400.75 million (down 1%, accounting for 9.3%) and Italy with nearly $307.27 million (up 1.6%, accounting for 7.2%). Meanwhile, imports from India also recorded a decrease of 9.1%, reaching $305.07 million.
The European Union accounts for over 50% of the trade volume.
Notably, the European Union (EU) remains Vietnam's primary source of pharmaceuticals. Imports from this bloc reached over US$2.33 billion this year, a 1.7% increase compared to 2024. With this result, pharmaceuticals from the EU now account for 54.3% of the country's total pharmaceutical imports.
Overall, the trend of pharmaceutical imports from most markets in 2025 shows a decrease in value compared to 2024. This fluctuation reflects adjustments in the supply chain and domestic market demand in the recent period.
